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Abstract 
Sufficient quantity and quality of skeletal muscle is required to maintain lifespan and healthspan into 
older age. The concept of skeletal muscle programming or memory has been suggested to contribute to 
accelerated muscle decline in the elderly in association with early life stress such as fetal malnutrition. 
Further, muscle cells in vitro appear to remember the in vivo environments from which they are derived 
(e.g. cancer, obesity, type II diabetes, physical inactivity and nutrient restriction). Tumour-necrosis 
factor alpha (TNF-α) is a pleiotropic cytokine that is chronically elevated in sarcopenia and cancer 
cachexia. Higher TNF-α levels are strongly correlated with muscle loss, reduced strength and therefore 
morbidity and earlier mortality. We have extensively shown that TNF-α impairs regenerative capacity 
in mouse and human muscle derived stem cells (Meadows 2000; Foulstone 2001, 2004; Stewart 2004; 
Al-Shanti 2008; Saini 2008; Sharples 2010). We have also recently established an epigenetically 
mediated mechanism (SIRT1-histone deacetylase) regulating survival of myoblasts in the presence of 
TNF-α (Saini 2012). We therefore wished to extend this work in relation to muscle memory of catabolic 
stimuli and the potential underlying epigenetic modulation of muscle loss. To enable this aim; C2C12 
myoblasts were cultured in the absence or presence of early TNF-α (early proliferative 
lifespan) followed by 30 population doublings in the absence of TNF-α, prior to the induction of 
differentiation in low serum media (LSM) in the absence or presence of late TNF-α (late proliferative 
lifespan). The cells that received an early plus late lifespan dose of TNF-α exhibited reduced 
morphological (myotube number) and biochemical (creatine kinase activity) differentiation vs. control 
cells that underwent the same number of proliferative divisions but only a later life encounter with 
TNF-α. This suggested that muscle cells had a morphological memory of the acute early lifespan TNF-α 
encounter. Importantly, methylation of myoD CpG islands were increased in the early TNF-α cells, 30 
population doublings later, suggesting that even after an acute encounter with TNF-α, the cells have the 
capability of retaining elevated methylation for at least 30 cellular divisions. Despite these fascinating 
findings, there were no further increases in myoD methylation or changes in its gene expression when 
these cells were exposed to a later TNF-α dose suggesting that this was not directly responsible for the 
decline in differentiation observed. In conclusion, data suggest that elevated myoD methylation is 
retained throughout muscle cells proliferative lifespan as result of early life TNF-α treatment and has 
implications for the epigenetic control of muscle loss. 
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Introduction 
Early evidence for the concept of skeletal muscle ‘memory’ has emerged from animal studies that 
investigated a phenomenon defined as ‘fetal programming.’ This notion referred to alterations in fetal 
growth and development in response to the prenatal environment having long term or permanent 
effects in later life. Original works 40 years ago, described early malnutrition during rat pregnancy 
reducing general cell numbers in the offspring (McLeod et al. 1972). In skeletal muscle it was initially 
observed that restricted-maternal nutrition by 60 % of the normal energy consumed was found to alter 
expression of Insulin-like-growth factor II (IGF-II) in ewe foetuses during gestation (Brameld et 
al. 2000). Since then, a wealth of evidence has suggested that both maternal carbohydrate and amino 
acid restriction leads to reduced fibre number and size (Fahey et al. 2005; Mallinson et al. 2007), 
altered protein synthetic signalling (Zhu et al. 2004) and even predisposes the offspring to obesity and 
type-II diabetes in later life (Samuelsson et al. 2008; Shelley et al. 2009; Zhu et al. 2006). These studies 
are suggestive of a programming or ‘memory’ of the foetal environment in the skeletal muscle of the 
offspring. In humans it has also been demonstrated, through epidemiological studies, that fetal 
programming and malnutrition have an effect on musculoskeletal development and are associated with 
changes in body composition into older age (Patel et al., 2010, 2011,2012, 2014, Sayer and 
Cooper 2005; Sayer et al. 2004). Importantly, reduced weight at birth is correlated with reduced grip 
strength and decreased muscle size (Funai et al. 2006; Gale et al. 2007; Inskip et al. 2006; Patel et 
al. 2010, 2011, 2014, 2012; Sayer et al.1998). These factors are associated with increased risk of 
disability, morbidity and mortality later in life (Gale et al. 2007; Laukkanen et al. 1995; Rantanen 2003; 
Rantanen et al. 1999, 2002). The molecular mechanisms of such a phenomenon and the concept of 
skeletal muscle programming/memory, particularly in the regulation of adult skeletal muscle mass 
growth and loss following changes in anabolic/ catabolic environments throughout the lifespan have 
not been directly investigated. 
Studies into the modulators of skeletal muscle growth alluding to a cellular retention have recently been 
investigated. Most notably, 3 months of testosterone administration in mice enabled muscle growth 
accompanied by increased myonuclei number that was retained during subsequent testosterone 
withdrawal despite muscle loss. The subsequent increase in muscle cross-sectional area following 6 
days of mechanical overload was 31 % in the animals that had received an earlier encounter of 
testosterone vs. controls who demonstrated no significant growth in the same time period (Egner et 
al. 2013). Further, a similar retention of overload bolstered myonuclei was observed during a 
subsequent period of denervation induced atrophy (Bruusgaard et al., 2010). While these studies are 
suggestive of adaptive physical phenomenon and not necessarily cell programming per 
se, they suggest that muscle retains a cellular potential following prior growth allowing it to respond to 
future growth stimuli more quickly and perhaps provide protection from periods of muscle loss. 
Conversely, skeletal muscle may also remember periods of catabolic environments. At the cellular level 
our group was the first to demonstrate that where muscle loss occurs in humans with cancer, muscle 
cells derived from these patients seem to retain a memory of the environment from which they were 
isolated. These cells exhibited inappropriate proliferative phenotypes in culture versus aged matched 
healthy controls (Foulstone et al. 2003). Recent studies collectively agree with these findings, 
confirming muscle derived cells do seem to remember their in vivo environment once isolated from 
different niches such as type II diabetes (Jiang et al. 2013), obesity (Maples and Brault 2015), 
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intrauterine growth restriction (Yates et al. 2014) and low physical activity levels (Green et al. 2013; 
Valencia and Spangenburg 2013). 
Although not investigated in the aforementioned studies, the most likely mechanistic underpinning of 
cellular programming or memory is epigenetic modifications. Epigenetic modifications broadly include 
histone modifications and DNA methylation that both alter access to enhancer and promoter regions of 
genes sometimes resulting in altered gene expression. These epigenetic changes have been shown to be 
transient e.g. methylated for a short period within a cell population following acute environmental 
stimuli, or extremely stable e.g. being passed to daughter generations of cells, the latter being linked to 
the concept of cellular programming. Despite its importance, and relevance to muscle 
adaptability following periods of growth due to hormonal manipulations/overloading exercise or 
muscle loss in catabolic disease states; research into the epigenetic regulation of gene expression in 
skeletal muscle is in its infancy. Currently, more data do however exist regarding the epigenetic control 
of muscle stem cells and the process of myogenesis (Campos et al. 2013; Dilworth and Blais 2011; 
Hupkes et al. 2011). The muscle specific transcription factor myoD is fundamental in muscle cell lineage 
determination and for early stages of myoblast differentiation (Blais et al. 2005; Cao et al.2006) via the 
initiation of p21Cip and irreversible cell cycle exit in G1, a prerequisite for myoblast fusion. MyoD has 
been shown recently to be bound to a third of gene enhancer regions when a whole genome CHIP assay 
was performed (Blum et al. 2012), suggesting an important role for myoD in the epigenetic control of 
muscle cell growth and regeneration. Our group has further begun to elucidate potential epigenetic 
modulators of myoblast survival and differentiation (Saini et al.2012), where activation 
of Sirtuin1 (histone deacetylase) reduced myoblast death and enabled differentiation in the presence of 
stress from TNF-α, a cytokine that is chronically up regulated in muscle loss conditions such as 
sarcopenia and cachexia. We have extensively shown that TNF-α impairs myoblast 
fusion/differentiation and myotube hypertrophy with corresponding reductions in myoD gene 
expression in mouse and human muscle cells (Meadows 2000; Foulstone 2001, 2004; Stewart 2004; 
Al-Shanti 2008; Saini 2008; Sharples 2010). Thus, together with the above studies, this perhaps 
provides compelling yet preliminary data suggesting that epigenetic mechanisms such as myoD 
methylation could be involved in TNF-α induced reduction in differentiation and myotube atrophy in 
muscle cells and potentially be involved in muscle cell programming/memory. 
In an attempt to study the impact of catabolic encounters with TNF-α on the ability of skeletal muscle 
to remember such an encounter, in the present study we aimed to use a novel cellular model that 
exposed proliferating myoblasts to an early experimental lifespan stimulus of catabolic TNF-α, followed 
by multiple population doublings (30 doublings similar to  methods used in (Sharples et al. 2011, 2012) 
in the absence of TNF-α, prior to the induction of differentiation in the absence or presence of a later 
second experimental lifespan  dose of TNF-α. This model allowed us to elucidate whether muscle cells 
‘remembered’ a prior catabolic stress when they encountered it again during differentiation later in 
their proliferative lifespan and investigate potential epigenetic modulation of muscle cell memory. We 
hypothesised that an early experimental life encounter with TNF-α would be ‘remembered’ by skeletal 
muscle cells when TNF-α was re-encountered in later proliferative life. Also, this memory would be 
associated with reductions in differentiation and associated myotube atrophy versus relevant control 
cells that underwent the same number of replicative divisions in vitro without encountering TNF-α. 
Further, that this increased susceptibility to TNF-α in the presence of a second, later dose of TNF-α 
would be associated with altered myoD methylation and subsequent changes in myoD gene expression. 
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Methods 
General cell culture 
C2C12 mouse skeletal myoblasts (Blau et al. 1985; Yaffe and Saxel 1977) were incubated in T75 flasks in 
a humidified 5 % CO2atmosphere at 37 °C in growth medium (GM), composed of: DMEM plus 10 % hi 
fetal bovine serum, 10 % hi newborn calf serum, 1 %l-glutamine (2 mM final), and 1 % penicillin–
streptomycin solution, until 80 % confluence was attained. Differentiation experiments were initiated 
by washing with PBS, and transferring into Low Serum Media (LSM) composed of: DMEM plus 2 % hi 
horse serum, 1 %l-glutamine, and 1 % penicillin–streptomycin (both as above)  in the absence or 
presence of TNF-α (20 ng ml−1). A dose extensively characterised by ourselves and others to be an 
inhibitor of differentiation in mouse and human muscle cells (Foulstone et 
al.2001, 2003, 2004, 2010, 2011; Stewart et al. 2004; Tolosa et al. 2005). C2C12 cells undergo 
spontaneous differentiation into myotubes on serum withdrawal, and do not require growth factor 
addition to stimulate the process (Blau et al. 1985; Tollefsen et al.1989). 
In-vitro model to assess myoblast programming/memory: Population doubling and establishing the 
‘early life’ encounter with TNF-α 
A schematic for deriving the three cell populations (CON, PD, αPD defined below) is depicted in Fig. 1. 
Briefly, 106 C2C12cells from the same vial were incubated in a pre-gelatinised T75 flask (0.2 % gelatin, 
Sigma, UK) in GM for 72 h until approximately 80 % confluent. The cells were washed × 2 with PBS and 
trypsinised, counted and split between three new T75’s and left to grow for a 24 h in GM before being 
washed × 2 with PBS. One flask was transferred to LSM + TNF-α for 48 h and the other two were 
transferred to LSM alone. There was no sign differentiation/fusion or dead cells (determined by trypan 
blue exclusion) during this period. One of the LSM alone flasks was trypsinised, centrifuged, pelleted 
and re-suspended in GM plus 1 % DMSO in cryovials and frozen in liquid nitrogen to create a stock of 
control (CON) population cells (i.e. no early experimental life dose of TNF-α and no population 
doublings vs. other daughter populations below). The other LSM alone flask was also trypsinised and 
plated back onto new T75’s in GM where the cells underwent 10 passages (30 population doublings) 
after which cells were frozen down as described above to derive the population doubled (PD) cell 
populations. Finally, in parallel to the PD cells the LSM + TNF-α T75 flask was also re-plated and 
transferred back to GM and passaged ten times (30 divisions) where cells were subsequently frozen 
down to create the ‘early life’ TNF-α encounter cell type that had also been population doubled (αPD). 
Differentiation experiments 
The three cell populations (CON, PD, αPD) were brought up from liquid nitrogen. They were plated at 
106 cells.ml−1 in separate T75’s in GM and incubated in a humidified 5 % CO2 atmosphere at 37 °C for 
72 h until 80 % confluent. Cells were collected following trypsinisation, and were counted in the 
presence of trypan blue dye. All cells (CON, PD and αPD) were seeded at 8 × 104 cells.ml−1 (in 2 ml) in 
each well of a six well plate and incubated for 24 h in GM. Cells were washed twice with PBS and 
transferred to 2 ml LSM.well−1 in the absence or presence of TNF-α (20 ng.ml−1) for up to 72 h (cell 
treatments and abbreviations can be seen in Table 1). Cells were harvested for counting, total protein 
and creatine kinase (CK) assays as well as mRNA and DNA for reverse transcription quantitative real 
time polymerase chain reaction (rt-qRT-PCR) and high resolution melting PCR for gene expression and 
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DNA (CpG) methlyation respectively. Time point zero (DM0) was defined as 30 min subsequent to 
transferring into DM ± TNFα. Analytical assays described above and detailed below were performed on 
at least n = 3/4 independent experiments of the derived cell populations with technical replicates being 
performed for each independent experiment, details of which can be found in the corresponding figure 
legends where the data is presented.  
Assessment of morphological differentiation 
Morphological differentiation was assessed using cell imaging (Leica, DMI 6000 B). All images were 
obtained at 0 and 72 h following transfer into LSM or TNF-α 20 ng.ml−1. Myotube number, diameter 
and area were derived from 72 h images using Image J software (Java soft-ware, National Institutes of 
Health, USA). Myotube number was counted per image and a global mean ± SD across all images per 
experimental condition was determined (to avoid including cells undergoing mitosis, a myotube was 
defined as containing 3+ nuclei encapsulated within cellular structures). For myotube diameter (μm); 
three widths (equidistantly spaced) were calculated on each myotube and averaged to determine the 
mean width per myotube. Myotube area (μm2) was determined by tracing around myotube structures 
using image J ‘freehand selection’ option. To derive mean myotube diameters and areas per treatment, 
these assessments were repeated for every myotube per image and a global mean ± SD was calculated 
across all images per cell treatment. Pixel length was converted to μm using Image J and 
Leica scaling. Morphological analysis was undertaken on images at 20X magnification. Details of 
number of images analysed per condition can be found in the specific figure legends. 
Total protein and creatine kinase activity (biochemical marker of differentiation) assays 
Cells were extracted for total protein and CK (creatine kinase) assays at 0 and 72 h. Cells were 
washed × 2 in PBS, lysed and scraped in 200 µl well−1 0.05 M Tris/MES Triton lysis buffer (TMT: 
50 mM Tris-MES, pH 7.8, 1 % Triton X100) and assayed using commercially available BCA™ (Pierce, 
Rockford, IL, USA) and CK activity (Catachem Inc., Connecticut, N.E, USA) assay kits according to 
manufacturer’s instructions. The enzymatic activity for CK was normalised to total protein content. 
RNA isolation, primer design, reverse transcription quantitative real time polymerase chain reaction 
(rt-qRT-PCR) and analysis 
For rt-qRT-PCR experiments cells were lysed in 250 μl/well TRIZOL reagent (Invitrogen Life 
Technologies, Carlsbad, CA). The RNA was isolated according to manufacturer’s instructions and 
quantified using UV spectroscopy at ODs of 260 and 280 nm, using the Nanodrop spectrophotometer 
3000 (Fisher, Rosklide, Denmark). Purity of samples was assessed by 260:280 nm ratio’s that ensured 
end values between 1.9 and 2.15. Identification of primer sequences (see below) was enabled by Gene 
(NCBI, www.ncbi.nlm.nih.gov/gene) and designed using OligoPerfectTM Designer (Invitrogen, 
Carlsbad, CA, USA) and/or Primer-BLAST (NCBI, http://www.ncbi.nlm.nih.gov/tools/primer-blast). 
Primers were purchased from Sigma (Suffolk, UK). Sequence homology (BLAST) searches ensured  the 
primers only matched the intended sequence and therefore gene that they were designed for. Primers 
were made to exclude self-dimer, hairpins and cross-dimers. All primers designed were between 18 and 
23 bp and the GC content ranged between 43 and 50 %. Gene names, Ref. Seq. No., primer sequences 
and product length were as follows: MyoD, NM_010866.2 Fwd: CATTCCAACCCACAGAAC Rev: 
GGCGATAGAAGCTCCATA, 125 bp. RPIIb (polr2b), NM_153798.2, Fwd: 
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GGTCAGAAGGGAACTTGTGGTAT Rev: GCATCATTAAATGGAGTAGCGTC, 197 bp. 
rt-qRT-PCR was carried out using QuantiFast™ SYBR® Green RT-PCR one-step kit on a Rotogene 
3000Q (Qiagen, Crawley, UK) supported by Rotogene software (Hercules, CA, USA). Reverse 
transcription was performed on the isolated mRNA at 50 °C (for 10 min), followed by 5 min 95 °C 
(transcriptase inactivation and initial denaturation), followed by: 10 s, 95 °C (denaturation), 30 s, 60 °C 
(annealing and extension) for 40 cycles. At the end of the cycling, melt curve analysis (50–99 °C at 1 °C 
increments) allowed identification of non-specific amplification or primer-dimer issues, none were 
apparent for the primer sequences listed in above methods. All PCR efficiencies were comparable 
(93.04 ± 4.32 %) across all conditions and genes. Relative mRNA expression was quantified for myoD 
using the comparative Ct (ΔΔCt) method (Schmittgen and Livak, 2008) against a stable reference gene 
of RPIIb (polr2b) (combined Ct value across experimental conditions 16.05 ± 0.31) and calibrator of 
CON cells in LSM at 0 h. 
DNA isolation 
Cells were washed × 2 in PBS (2 ml well−1) and incubated for 1.5 h at 37 °C in 250-300 µl of sterile 
filtered DNA lysis buffer: 1.5 M Tris pH 8.8, (Sigma T1503), 0.25 M EDTA (Sigma E5134), 4 M NaCl, 
0.02 % TritonX-100, and 100 µg ml−1 Proteinase K (Sigma P4850). The wells were scraped and cell 
lysate collected and centrifuged 14,000 rpm at room temperature for 5 min. The supernatant was 
collected (contains DNA) and an equal volume of isopropanol/NaCl (100 mM) was added and 
incubated overnight at −20 °C. The sample was next centrifuged for 20 min at 14,000 rpm, the 
supernatant removed and the DNA pellet reconstituted in TE, pH 8 supplemented with RNase 
(Ribonuclease A, 10 mg ml−1) and incubated for 1 h at 37 °C before being vortexed and stored for 
downstream applications at −80 °C. DNA was bisulfite converted (Epitect Bisulfite conversion kits, 
Qiagen, Manchester, UK) according to manufacturer’s instructions and quantified using UV 
spectroscopy (Nanodrop spectrophotometer 3000, Fisher, Rosklide, Denmark) using the single 
stranded DNA conversion factor (at 260 nM the coefficient of extinction for single-stranded DNA is 
0.027 μg ml−1 cm−1, thus, an OD of 1 corresponds to a concentration of 33 μg ml−1 for single-stranded 
DNA). Once bisulfite converted, DNA was stored in −80 °C in Qiagen’s elution buffer until required for 
HRM PCR (below). 
High resolution melting polymerase chain reaction (HRM PCR) for CpG assays and methylation 
analysis 
20 ng of DNA was used per HRM PCR reaction and carried out using EpiTect™ HRM PCR kits that 
used Eva Green® as the DNA intercalating fluorescent dye on a Rotogene 3000Q (Qiagen, Crawley, 
UK) supported by Rotogene software (Hercules, CA, USA). Primer concentrations for CpG assays and 
EpiTect™ HRM master mix volumes were used according to manufacturer’s instructions. CpG assay 
primers were bought directly from Qiagen. All primers amplified regions containing CpG sites that 
were located around the myoD promoter associated region i.e. located Chr7:53,632,013-53,632,677. 
Primers were as follows: (myoD (01) geneglobe cat no; PM00388241, location Chr7: 53,632,013-
53,632,218: myoD (02) cat no: PM00388248, location Chr7:53,632,095-53,632,222: myoD (o3) cat no: 
PM00388262, location Chr7:53,632,188-53,632,345: myoD (04) cat no: PM00388269, location 
Chr7:53,632,463-53,632,677. All primers designed amplified a product between 119 and 214 bp. PCR 
cycles were as follows: 10 s, 95 °C (denaturation), 30 s, 55 °C (annealing) 10 s, 72 °C extension for a 
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maximum of 55 cycles. Following PCR a high resolution melt (HRM) protocol was undertaken on the 
PCR products where the products were melted at 0.1 °C increments from 65 to 95 °C. This gave high 
resolution melt curves for fluorescence (y axis) versus melt temperature (x axis). A standard curve using 
the melt analysis was created using methylated mouse DNA standard controls (100, 75, 50, 25, 10, 5, 
0 % methylated; EpigenDX, MA, USA) that also underwent the same bisulfite conversion as 
experimental samples, PCR and HRM as described above (this included a 100 % methylated control 
sample that had not been bisulfite converted to act as a negative control). All samples were run in 
duplicate. Duplicate samples were normalised to 0 % methylated controls and averaged to produce a 
single curve (Fig. 3a). The relationship between the area under the curve, determined from integration 
of each standard curve, and the corresponding percentage of methylation was defined via the best 
fitting fourth-order polynomial relation (Fig. 3b). The correlation coefficients we obtained were 
typically high r ≤ 0.98 and indicate high precision across the full percentage range. This calibrated 
relationship was used to quantify the % methylation from the integrated raw melt curves of 
experimental samples. The percentages were normalised to CON LSM 0 h conditions to indicate fold 
change in percentage methylation. These calculations were performed using a bespoke Python-based 
program, MethylCal (T. M. Hughes). 
Statistical analyses 
Statistical analyses and the significance of the data were determined using minitab version 17.0. Results 
are presented as mean ± standard deviation (SD). Data were scanned for potential outliers using stem 
and leaf plots and all data was deemed to be normally distributed and satisfy homogeneity of variance 
tests. Statistical significance for interactions between cell type (CON, PD, αPD) and dose (DM, TNF-α 
20 ng.ml-1) at 72 h was determined using (3 × 2) mixed two-way Factorial ANOVA for all dependent 
variables (CK, myotube number/diameter/area, myoD transcript expression, and myoD 01,02,03,04 
and pooled CpG island methylation. Bonferroni and Tukey post hoc tests were conducted for all 
pairwise comparisons (unless otherwise stated in the text and as detailed in the figure legends). If 
Bonferroni pairwise comparisons were not significant and Tukey significant then this was detailed in 
the figure legends. For all statistical analyses, significance was accepted at P ≤ 0.05. 
Results 
Morphological and/ biochemical differentiation and myotube hypertrophy 
Basally, 30 population doublings alone (PD) cells demonstrated a significant reduction in 
differentiation and myotube hypertrophy vs. CON cells (Fig. 2a); where biochemical differentiation/CK 
activity (PD 345.2 ± 48.4 vs. CON 445.1 ± 60.6 mU.mg.ml−1; P ≤ 0.05; Fig. 2b), myotube number (PD 
2.78 ± 0.833 vs. CON 3.46 ± 0.519; P ≤ 0.05; Fig. 2c) and myotube area (PD 9335 ± 2468 vs. CON 
13,677 ± 2395 µm2; P ≤ 0.05; Fig. 3e) were significantly reduced, yet myotube diameter unchanged 
(Fig. 2d). Interestingly, an early experimental life dose of TNF-α followed by 30 population doublings 
(αPD) was unable to reduce differentiation significantly vs. PD cells alone (myotube number: αPD 
2.77 ± 0.439 vs. PD 2.78 ± 0.83; diameter: αPD 21.97 ± 1.67 vs. PD 22.74 ± 2.22 µm, area: αPD 
7047 ± 1976 vs. PD 9335 ± 2468 µm2; P = NS; Fig. 2c, d, e respectively) suggesting no impact of an 
‘early life’ encounter with TNF-α after 30 population doublings versus the relevant PD control, at least 
when cells are induced to differentiate under basal (LSM alone, i.e. no TNF-α) conditions. 
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TNF-α reduced differentiation (CK and myotube number) and myotube area in CON cells (CK: CON 
445.1 ± 60.6 vs. CONα 237.9 ± 47.2 mU.mg.ml−1; myotube number: CON 3.46 ± 0.519 vs. CONα 
2.615 ± 0.519; area: CON 13,677 ± 2395 vs. CONα 9577 ± 1924 µm2; all P ≤ 0.05; Fig. 2b, c, e 
respectively). Similarly, TNF-α significantly reduced biochemical differentiation in PD cells versus their 
own basal control (CK: PD 345.2 ± 48.4 vs. PDα 231.5 ± 29.6 mU.mg.ml−1, P ≤ 0.05; Fig. 2b) where 
there were also average, yet non-significant reductions in morphological analysis of differentiation and 
hypertrophy (myotube number: PD 2.78 ± 0.83 vs. PDα 2.0 ± 0.54; diameter: PD 22.74 ± 2.22 vs. PDα 
20.3 ± 1.66 µm, P = N.S. Fig. 2c, d). Despite lack of significance on the latter parameters, there were 
larger absolute reductions in differentiation (myotube number) and hypertrophy (myotube diameter) 
observed in PD cells with TNF-α administration that resulted in significant differences vs. CON cells in 
the presence of TNF-α (myotube number: PDα 2.0 ± 0.54 vs. CONα 2.615 ± 0.519; diameter: PDα 
20.31 ± 1.66 vs. CONα 22.9 ± 2.35 µm; all P ≤ 0.05, Fig. 2c, d respectively), with again average but non-
significant reductions in myotube area (PDα 7224 ± 2847 vs. CONα 9577 ± 1924 µm2, P = N.S; Fig. 2e). 
Importantly, the largest average absolute reductions in differentiation were in cells that had received an 
early proliferative lifespan encounter with inflammatory cytokine TNF-α and undergone subsequent 30 
population doublings and then encountered a later life cytokine challenge during differentiation (αPDα 
cell population) vs. PD cells without the early encounter with TNF-α, but differentiated in the presence 
of TNF-α (PDα) (myotube number αPDα 1.54 ± 0.52 vs. PDα 2.0 ± 0.54, diameter αPDα 18.93 ± 1.8 vs. 
PDα 20.31 ± 1.66, area αPDα 6022 ± 1038 vs. PDα 7224 ± 2847, P = N.S.; Fig. 2c, d, e respectively), 
where differences in biochemical differentiation (CK activity) resulted in significance (αPDα 
165.5 ± 19.81 vs. PDα 231.5 ± 29.6 mU.mg.ml−1, P ≤ 0.05; Fig. 2b). Overall, the results above lead to 
significant interactions between dose and cell type for CK activity and myotube area (both P ≤ 0.05). 
The cells that had received an early experimental life encounter with TNF-α, retained a memory, at 
least with respect to differentiation, when they encountered an inflammatory catabolic stress was 
experienced again during later life differentiation, where these cells showed the lowest average absolute 
reductions in all parameters versus all other conditions. 
MyoD CpG methylation 
We next wished to assess the role of CpG island methylation of myoD to evaluate the impact of potential 
hypo/hypermethylation on corresponding increases or decreases respectively in myoD gene expression 
(see below). The largest fold increases in methylation above baseline were in cells exposed to the early 
encounter with TNF-α, expanded over 30 doublings before being cultured in LSM and induced to 
differentiate versus their relevant controls (PD). This held true across all CpG islands studied (Fig. 3c–
g). When analysed further, there was a significant main effect for cell type for all CpG islands 
investigated (myoD 01: P = 0.05, Fig. 3c; myoD02: P = 0.002, Fig. 3d; myoD03: P = 0.035, Fig. 3e; 
myoD 04: P = 0.006, Fig. 3f). When relative fold changes were pooled across all CpG assays (Fig. 3g) 
there was a significant main effect for cell type (P ≤ 0.001), dose (P = 0.003) and a significant 
interaction for cell type × dose (P = 0.012). Specifically, there was a significant pairwise comparisons 
for αPD versus CON and αPDα versus PD for CpG island myoDo2 (αPD 1.61 ± 0.07 vs. CON 
1.25 ± 0.02, P ≤ 0.05 and αPDα 1.5 ± 0.07 vs. PD 1.35 ± 0.07, P ≤ 0.05) and αPD versus PD for CpG 
island myoD04 (αPD 2.06 ± 0.03 vs. PD 1.36 ± 0.07, P ≤ 0.05). There were also significant pairwise 
comparisons (Fisher LSD) between αPD versus PD for CpG island myoDo1 (αPD 1.55 ± 0.27 vs. PD 
1.3 ± 0.15 and CON 1.23 ± 0.1, P ≤ 0.05), αPD versus PD and CON for CpG island myoD02 (αPD 
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1.61 ± 0.07 vs. PD 1.35 ± 0.07 and CON 1.25 ± 0.02, P ≤ 0.05), myoDo3 (αPD 2.32 ± 0.21 vs. PD 
1.54 ± 0.07 and CON 1.61 ± 0.2, P ≤ 0.05) and myoD04 (αPD 2.06 ± 0.03 vs. PD 1.36 ± 0.07 vs. CON 
1.44 ± 0.03, P ≤ 0.05). Importantly, when relative fold change data were pooled across CpG assays 
(Fig. 3g) there was also a significant pairwise comparisons for αPD vs. PD and CON (αPD 1.89 ± 0.36 
vs. PD 1.39 ± 0.12 and vs. CON 1.38 ± 0.12, P ≤ 0.05), suggesting that an acute early experimental life 
encounter with TNF-α alone is powerful enough to be conserved through 30 population doublings and 
remain elevated in basal LSM. 
Although methylation did not increase further in cells that had experienced an early experimental life 
encounter with TNF-α and then received a second TNF-α encounter upon differentiation (αPDα), the 
higher mean levels in αPD were sustained in this condition in myoD01, 02 and 04 (actually reduced for 
myoD03, yet was not significant) evident by no significant differences with αPD for all CpG islands 
analysed (all αPDα vs. PDα comparisons, P = N.S.). After pooling all CpG fold changes there 
was indeed significantly reduced methylation in αPDα conditions vs. αPD (αPDα 1.52 ± 0.13 vs. αPD 
1.89 ± 0.36), however, αPDα vs. PDα or PD alone were not significantly different. 
MyoD gene expression changes 
In the present study TNF-α reduced myoD expression in all cell types resulting in a significant main 
effect for dose (LSM pooled mean 2.179 vs. TNF-α pooled mean 1.01, P ≤ 0.001; Fig. 4); with significant 
post hoc comparisons in for LSM control versus TNF-α dosed (CON 2.7 ± 0.57 vs. CON α 1.15 ± 0.55, 
P ≤ 0.05; PD 1.84 ± 0.34 vs. PDα 0.86 ± 0.47, P ≤ 0.05; αPD 1.91 ± 0.31 vs. αPDα 0.87 ± 0.26, 
P ≤ 0.05). Furthermore, there was also a significant main effect for cell type (P = 0.028) suggesting that 
myoD expression was reduced to the greatest extent in the PD and αPD cells versus CON regardless of 
dose (αPD 1.39, PD 1.35 vs. CON 1.93). Further, TNF-α administration during differentiation resulted 
in the largest average reductions were in both PD and αPD cell types resulting in a significant difference 
vs. PD LSM for both cell types (PDα 0.86 ± 0.47 and αPDα 1.032 ± 0.42 vs. PD 1.85 ± 0.34; P ≤ 0.05). 
Although cells that had undergone an early stimulus with TNF-α, undergone multiple population 
doublings and received a subsequent dose upon serum withdrawal and differentiation (αPDα cells) 
exhibited reductions in differentiation, myoD however, was also comparably reduced in PD cells in the 
presence of TNF-α (PDα 0.86 ± 0.47 and αPDα 1.032 ± 0.42, P = N.S.). 
Discussion 
The present study demonstrates for the first time that muscle cells exposed to an early experimental life 
(pre-population doubling) dose of TNF-α (αPD cells) were more susceptible to a subsequent post-
population doubling encounter with the same cytokine. The cytokine induced larger absolute reductions 
in morphological/biochemical differentiation versus relevant non-treated, population doubled control 
cells. We also present novel findings suggesting that these cells retain increased methylation of myoD 
following their early experimental ‘life’ proliferative encounter with TNF-α and retain these 
hypermethlyated patterns even after a subsequent 30 population doublings. Despite methylation 
remaining higher with the second later life TNF-α stimulus versus PD alone, it was not further elevated 
versus cells that received TNF-α at an early proliferative stage alone. This suggested, in opposition to 
the original hypothesis, that despite an increased susceptibility to reductions in differentiation and 
associated myotube atrophy in the cells that received an early plus later life dose of TNF-α, myoD 
methylation does not seem to be driving this morphological response. Furthermore, in disagreement 
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with the original hypothesis, myoD hypermethylation in these cells did not correspond with reductions 
in myoD gene expression that appeared to be the same in the cells that had received the early 
experimental life encounter of TNF-α (αPD cells) versus population doubled (PD) alone cells. Finally, 
myoD gene expression for both population doubled alone cells (PD) versus those that had received an 
early experimental life dose of TNF-α and subsequently population doubled (αPD) were not further 
impaired in the presence of TNF-α during differentiation. Therefore, despite showing that cells that 
encounter an acute early life insult of TNF-α seem to have increased methylated CpG regions, myoD 
expression per se may not be the main driver of reduced differentiation observed when these cells 
encountered a second later life TNF-α insult. We also observed a similar trend to that of myoD for both 
myogenin and IGF-I gene expression (data not shown) suggesting that MRF’s or IGF-I family members 
were also not the main driver of TNF-α induced reductions in differentiation, which therefore may be 
hypothesised to come as a result of altered cellular signalling processes e.g. via p38 MAPK 
phosphorylation as its activity has been previously suggested to be heavily involved in TNF-α induced 
impairments in differentiation (Chen et al. 2007). However, this requires future investigation as to its 
role in potential morphological memory observed in the present study. It could also be further 
hypothesised that after early experimental life doses of inflammatory cytokines, subpopulations of cells 
may become quiescent once the environmental stress has ceased, harbouring epigenetic alterations that 
could be preserved over many daughter populations. Therefore, these are the cells that retain altered 
methylated regions while muscle cell function maybe somewhat preserved in the majority of the 
population. This is certainly warrants further investigation in the present in vitro model. 
Overall, however, we present novel findings that suggest upon administration of a cytokine in early 
proliferative life, muscle cells increase and retain these hypermethylated regions even after subsequent 
30 population doublings. Despite epigenetic mechanisms seemingly not underpinning the worsened 
biochemical and morphological differentiation following a later life exposure to TNF- α, there never the 
less appears to be a preservation of epigenetic status in muscle cells following an acute cytokine stress. 
Future large scale methylome studies to identify CpG islands associating in cis (mapping to gene 
location) are required in this model to investigate the potential impact of TNF-α on CpG methylation 
acutely and over time in skeletal muscle cells. These pertinent studies would identify CpG islands across 
all genes and how/if these regulate the impaired differentiation and myotube hypertrophy experienced 
in muscle cells that have had early life cytokine encounters.  
A so called ‘memory’ as a concept has been recently alluded to whereby 3 months of testosterone 
administration in mice enabled muscle growth accompanied by increased myonuclei numbers that, 
interestingly, were retained during subsequent testosterone withdrawal despite muscle size losses. Most 
importantly, the subsequent rate of growth response following mechanical overload (resistance 
exercise) was a 31 %  increase in muscle cross-sectional area in the animals that had received an earlier 
encounter of testosterone (Egner et al. 2013) versus control animals. This accompanied earlier work by 
the same group that suggested myonuclei acquired by mechanical overload are retained during a 
subsequent atrophic event (Bruusgaard et al. 2010). While this is an adaptive physical phenomenon and 
not necessarily cell programming per se, these studies importantly suggest that muscle retains a cellular 
potential following prior growth allowing it to respond to future growth stimuli more quickly, 
importantly allowing protection during subsequent periods of muscle loss. In the present study we were 
investigating differentiation and myotube hypertrophy following a catabolic stress, not the role of prior 
fused myonuclei following a hypertrophic stimulus. However, the present in vitro model could easily be 
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manipulated to investigate the impact on established myotubes with a hypertrophic stimulus from 
testosterone, IGF-I or even exercise stimuli via mechanical stretch or electrical stimulation in vitro in 
monoloayer or using three dimensional bioengineered skeletal muscle e.g. (Player et al., 2014). It is 
worth noting that there are limited studies assessing DNA methylation post exercise particularly with 
respect to a memory of earlier exercise or nutritional encounters. Notably, a recent study in skeletal 
muscle, demonstrated acute metabolic stress (aerobic exercise) reduces DNA methylation of enhancer 
regions (hypomethlyation) of genes associated with mitochondrial biogenesis (PGC-1α, PDK4 and 
PPAR-δ) that presumably in turn allowed increased promoter activity (although not directly 
investigated) and thus increased corresponding transcript expression (Barres et al. 2012). Similarly a 
more recent study suggests that acute nutritional manipulation (fasting) in combination with acute 
exercise also provides evidence of an inverse relationship with DNA methylation and gene expression of 
important metabolic genes involved in substrate utilization (Lane et al. 2015). However, adaptation in 
the terms of stable methylation patters after chronic anabolic exercise stimuli or periods of catabolic 
injury/disuse remains unstudied, as do methylation of genes that control muscle mass. 
Our groups’ earlier work has shown that human muscle cells derived from negative environment such 
cancer patients remember the environment from which they were derived where they actually exhibited 
inappropriate proliferative phenotypes versus aged matched healthy controls (Foulstone et al. 2003). 
More recently this concept has been confirmed and discussed by four further papers (three original 
works, one review). They collectively suggest muscle derived cells retain a memory once isolated from 
different environmental niches: (1) muscle derived cells from humans who are physically active, display 
an improved ability to uptake glucose and are somewhat protected from palmitate induced insulin 
resistance versus cells isolated from sedentary humans (Green et al. 2013; Valencia and 
Spangenburg 2013); (2) muscle derived cells from obese patients do not respond to lipid oversupply 
with the same gene expression signatures versus control (Maples and Brault 2015); (3) muscle derived 
cells from intrauterine growth-restricted sheep fetuses exhibit deficiencies in proliferation versus 
controls (Yates et al. 2014). Importantly all of these studies, highlight that muscle derived stem cells 
with mitotic potential could be important in the concept of programming/memory in skeletal muscle 
tissue. The latter is particularly pertinent given a recent in vivo study suggesting protein restriction in 
maternal rats results in what the authors termed ‘metabolic inflexibility’ in the resulting 
offsprings skeletal muscle; where impaired expression of genes that increase the capacity for fat 
oxidation in response to fasting was observed (Aragao et al. 2014). Given that malnutrition during 
pregnancy is also associated with the progression of sarcopenia into old age in humans, the 
mechanisms of muscle memory of negative encounters is a particularly pertinent avenue for future 
research. The only study, other than the data in this manuscript, to investigate potential epigenetic 
modulation of cell memory from negative environmental encounters was in a recent study where lipid 
oversupply in obese patients muscle derived cells possessed increased DNA methylation of PPARδ with 
subsequent larger reductions in PPARδ gene expression vs. non obese controls (Maples and 
Brault 2015). Despite the subjects in the control group not being age matched with the obese group, 
where the obese group were on average almost 7 years older, this study, together with present results, 
implies that epigenetics could be important in muscle memory and impact on skeletal muscle 
adaptation and function during negative environmental encounters. 
In summary: This study showed that skeletal muscle cells have increased susceptibility in late 
proliferative life to TNF-α stress when the cells have experienced an earlier, acute TNF-α encounter. 
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This is suggestive of a morphological memory of catabolic stress in myoblasts. Importantly, muscle cells 
that have experienced even an acute cytokine stress in early life possess an elevated myoD methylation 
status that is retained into later proliferative lifespan. Despite this, there were no further increases in 
myoD methylation or gene expression when these cells experienced a further cytokine stress in later 
life, suggesting that in this model and at the times points studied, epigenetic control of myoD gene 
expression was not driving the observed morphological memory of increased susceptibility to TNF-α. It 
remains to be seen if these observations can be recapitulated in vivo especially when satellite cells are so 
efficient at proliferating and regenerating muscle, even with age (e.g. Collins et al. 2005, 2007). This 
study does however suggest an important potential epigenetic mechanism via retention of DNA 
methylation throughout proliferative lifespan in muscle cells following inflammatory stress that is 
potentially associated with muscle loss into old age of humans. 
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Table 1. Myoblast differentiation experiments culturing conditions. 
 
Time Point/ 
Denotation 
Description of Differentiation Culture Conditions 
CON 0 CON cells 30 minutes in LSM  
CON 72 
CON α 72 
PD 0 
PD 72 
CON cells 72 hrs in LSM  
CON cells 72 hrs in LSM supplemented with TNF-α (20 
ng.ml-1) 
Population doubled cells 30 minutes in LSM 
Population doubled cells 72 hrs in LSM 
PD α 72 
 
αPD 0 
αPD 72  
 
αPD α 72 
Population doubled cells 72 hrs in LSM supplemented with 
TNF-α (20 ng.ml-1) 
‘Early life’ TNF-α (40 ng.ml-1) & population doubled cells 
LSM for 30 minutes 
‘Early life’ TNF-α (40 ng.ml-1) & population doubled cells 
LSM for 72 hrs 
‘Early life’ TNF-α (40 ng.ml-1) & population doubled cells 
72 hrs in LSM supplemented with TNF-α (20 ng.ml-1) 
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Fig. 1 
Schematic diagram for generation of (1) control cells (no doublings relative to population doubled cells, 
(2) population doubled (PD) cells (30 divisions) and (3) Cell that have had an acute TNF-α exposure in 
their early proliferative life and subsequently undergo 30 population doublings (αPD). 
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Fig. 2 
a. Morphological images (10X) to assess differentiation, myotube number, diameter and area in control 
(CON), population doubled (PD) and population doubled plus early life acute TNF-α exposure (αPD) cell 
types at 72 h following transfer into Low serum media (LSM) or  LSM plus TNF-α administration (20 
ng.ml-1). b. Creatine Kinase activity in CON, PD and αPD cells in the absence (LSM) or presence of TNF-
alpha (α) CK. *Significantly different to CON LSM 72 h, **significantly different within cell type versus 
own LSM control, ***significantly different versus PD α. c. Myotube number in CON, PD and αPD cells in 
the absence (LSM) or presence of TNF-alpha (α). *Significantly different to CON LSM, **significantly 
different within cell type versus own LSM control, ***significantly different vs. CON α. d. Myotube 
diameter in CON, PD and αPD cells in the absence (LSM) or presence of TNF-alpha (α).*Significantly 
difference versus CON α. e. Myotube area in CON, PD and αPD cells in the absence (LSM) or presence of 
TNF-alpha (α). *Significantly different to CON LSM, **significantly different within cell type versus own 
LSM control. Morphological analysis was taken from n = 3 or 4 with 4–5 images per n. All significant data 
were performed using Bonferroni and Tukey post hoc pairwise comparisons. 
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Fig. 3 Relative fold changes of percent myoD CpG island methylation in CON, PD and αPD cells in the 
absence (LSM) or presence of TNF-alpha (α). a Example of 100, 75, 50, 25, 10, 5, 0 % methylated mouse 
DNA standard curve with duplicate samples normalised to 0 % methylated controls and averaged to 
produce a single curve. b An example of the relationship between the area under the curve, determined 
from integration of each standard curve, and the corresponding percentage of methylation using a best 
fitting fourth-order polynomial relation. cMyoD01: Location Chr7: 53,632,013-53,632,218. *Significantly 
different to CON LSM (Fisher LSD pairwise comparison), **significantly different to CON LSM (Fisher 
LSD pairwise comparison). d MyoD02: location Chr7:53,632,095-53,632,222. *Significantly different to 
CON LSM (Bonferroni/Tukey pairwise comparisons), **significantly different to PD LSM (Fisher LSD 
pairwise comparison). e MyoDo3: location Chr7:53,632,188-53,632,345. *Significantly different to CON 
LSM (Fisher LSD pairwise comparison), **significantly different to PD LSM (Fisher LSD pairwise 
comparison). f MyoD04: location Chr7:53,632,463-53,632,677. *Significantly different to CON LSM 
(Fisher LSD pairwise comparison), **significantly different to PD LSM (Tukey pairwise comparison 
only). gPooled myoD CpG island methylation: Location Chr7:53,632,013-53,632,677. *Significantly 
different to CON LSM (Bonferonni/Tukey pairwise comparisons), **significantly different to PD LSM 
(Bonferroni/Tukey pairwise comparisons) ***significantly different to αPD (Bonferroni/Tukey pairwise 
comparisons). Data are representative of n = 3 with the assay ran in duplicate. 
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Fig. 4 
Relative delta delta Ct expression value for myoD gene transcript expression in CON, PD and αPD cells in 
the absence (LSM) or presence of TNF-alpha (α). *Significantly different within cell type versus own LSM 
conditions (Bonferonni and Tukey pairwise comparisons), **significantly different within cell type versus 
own LSM conditions (Tukey pairwise comparison only), ***significantly different to own PD LSM 
conditions (Bonferroni and Tukey pairwise comparisons). Data are representative of n = 3 with the assay 
ran in duplicate. 
 
